Blocking CD47 with monoclonal antibodies promotes phagocytosis of tumor cells mediated by DCs, which in turn enhances antigen cross-presentation and activation of cytotoxic T Cells (Hsieh et al., 2022). This evidence concerns the gene CD47 and neoplasm.